๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Inhibition of Telomerase Activity and Secretion of Prostate Specific Antigen by Silibinin in Prostate Cancer Cells

โœ Scribed by THELEN, P.; WUTTKE, W.; JARRY, H.; GRZMIL, M.; RINGERT, R.-H.


Book ID
119957792
Publisher
Lippincott Williams and Wilkins
Year
2004
Tongue
English
Weight
405 KB
Volume
171
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Prostate-specific membrane antigen (PSMA
โœ Rena G. Lapidus; Carol W. Tiffany; John T. Isaacs; Barbara S. Slusher ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 202 KB ๐Ÿ‘ 2 views

## Background: Prostate-specific membrane antigen (psma) is a glutamate carboxypeptidase that cleaves terminal carboxy glutamates from both the neuronal dipeptide n-acetylaspartylglutamate (naag) and gamma-linked folate polyglutamate. the prostate enzyme has activity in both the membrane and cytoso

Prostate-specific antigen in screening o
โœ Dr. T. Ming Chu ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 467 KB ๐Ÿ‘ 1 views

Prostate-specific antigen (PSA) is a wellcharacterized human prostate-specific glycoprotein. PSA has been shown to be the most effective immunohistologic marker for prostate cancer, as well as the most useful serologic test in staging and monitoring prostate cancer and in early detection of recurren

Expression of prostate-specific antigen
โœ Joanne N. Davis; Omer Kucuk; Fazlul H. Sarkar ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 260 KB

Prostate cancer is the second-leading cause of cancer-related deaths in men in the United States. Unfortunately, there is no effective therapy when prostate cancer becomes metastatic and refractory to conventional treatments. For this reason, the identification and exploration of new agents that red